GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
12.0251 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
11.0692 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
9.75264 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALPL, AOX1, BCL2, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TYR, XDH |
9.72726 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, ESR1, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MET, PPARA |
9.32855 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, ESR1, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
8.65779 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, ALOX15, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, F10, F3, GPR35, HCAR2, HSPA1A, INSR, KDR, MET, MMP9, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
8.27993 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, ALOX15, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, F10, F3, GPR35, HCAR2, HSPA1A, INSR, KDR, MET, MMP9, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
8.26798 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALOX15, ALPL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, FABP3, FABP4, HSD11B2, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MMP2, PPARA, SMAD3, SRC, TEK, TYR |
8.09042 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, BCL2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, FABP3, HSD11B2, HSD17B2, IGF1R, INSR, MMP2, MMP9, PPARA, SRC, TEK, TYR |
8.03548 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX15, AOX1, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, FUT7, GBA2, HSPA1A, PPARA, TYR, XDH |
7.98471 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, AKR1B1, ALOX15, BCL2, CA12, CA2, CA7, CDK6, CYP19A1, CYP1A1, CYP1B1, EGFR, ESR1, F10, F3, FABP3, FABP4, GPR35, HCAR2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, INSR, KDR, MET, PPARA, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
7.78446 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX15, ALPL, AOX1, BCL2, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FUT7, GBA2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TYR, XDH |
7.17606 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, BCL2, CDC25B, CDK6, CSNK2A1, CYP1B1, EGFR, ESR1, ESRRA, F3, FABP3, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NUAK1, SMAD3, SRC, TEK, XDH |
6.8224 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, ALOX15, ALPL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, FABP3, FABP4, HSD11B2, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, PPARA, SMAD3, SRC, TEK, TYR |
6.74749 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, HSD11B2, IGF1R, INSR, MMP2, PPARA, SMAD3, SRC, TEK |
6.67388 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, HSD11B2, INSR, PPARA, SRC, TEK |
6.57402 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
6.40094 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, ALOX15, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, PPARA, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
6.25273 |
[BP] GO:0048513 |
animal organ development
|
ACHE, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, ESRRB, HSD11B1, HSD17B2, INSR, KDR, PPARA, SMAD3, SRC, TEK, TYR |
6.23868 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, BCL2, CDK6, CYP19A1, CYP1B1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
6.1712 |
[BP] GO:0033993 |
response to lipid
|
ALPL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, HSD11B2, HSD17B2, SRC, TYR |
6.10151 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, ALOX15, BCL2, CSNK2A1, CYP1B1, EGFR, F10, F3, GPR35, HSPA1A, INSR, KDR, MET, MMP9, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
6.04111 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, ALOX15, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, F10, F3, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
5.78047 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
5.75401 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, BCL2, CDK6, CYP19A1, CYP1B1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
5.75401 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, BCL2, CDK6, CYP19A1, CYP1B1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
5.74342 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, ALOX15, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, F10, F3, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
5.69223 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
5.46243 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, ALOX15, BCL2, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, F10, F3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PTPN1, SRC, TEK, XDH |
5.4293 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, AKR1B1, ALOX15, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, PPARA, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
5.42394 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, ALOX15, BCL2, CSNK2A1, CYP1B1, EGFR, ESRRA, F10, F3, FABP4, GPR35, HSPA1A, INSR, KDR, MET, MMP2, MMP9, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
5.37475 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CYP19A1, CYP1A1, CYP1B1, EGFR, ESR1, HCAR2, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
5.335 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, HSD11B2, SRC, TEK, TYR |
5.31336 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, PPARA |
5.31336 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, ALOX15, BCL2, CYP1B1, EGFR, F10, F3, GPR35, HSPA1A, INSR, KDR, MET, PTPN1, SRC, TEK, XDH |
5.27784 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, ALOX15, BCL2, CA2, CA7, CDK6, CSNK2A1, CYP19A1, CYP1B1, EGFR, F10, F3, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, PPARA, PTPN1, SMAD3, SRC, TEK |
5.08795 |
[BP] GO:0030335 |
positive regulation of cell migration
|
BCL2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
5.08795 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
5.01901 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX15, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD11B1, HSD11B2, HSD17B1, HSD17B2, TYR, XDH |
5.00529 |
[BP] GO:2000147 |
positive regulation of cell motility
|
BCL2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
4.94947 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, KDR, MMP9, SRC |
4.91554 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
BCL2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
4.83108 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALPL, AOX1, BCL2, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TYR, XDH |
4.82168 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.74736 |
[BP] GO:0040017 |
positive regulation of locomotion
|
BCL2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
4.69129 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.64162 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, AKR1B1, ALOX15, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, F10, F3, FABP4, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP2, MMP9, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
4.63878 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX15, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, FABP3, FABP4, FUT7, GBA2, MET, PPARA |
4.63874 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALOX15, ALPL, BCL2, CA2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESRRA, ESRRB, GBA2, HSD11B1, HSD17B2, INSR, KDR, MMP9, PPARA, SMAD3, SRC, TEK, TYR |
4.59456 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, ALOX15, ALPL, BCL2, CA2, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FABP4, FUT7, GBA2, HSD11B1, HSD17B2, INSR, KDR, MET, MMP2, MMP9, PPARA, SMAD3, SRC, TEK, TNKS2, TYR |
4.54511 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, AKR1B10, ALOX15, ALPL, BCL2, CYP19A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESRRB, F10, F3, FABP4, HSD11B2, HSD17B2, IGF1R, INSR, MET, MMP1, MMP2, MMP9, PPARA, SMAD3, SRC, TEK, TNKS2, TYR |
4.51829 |
[BP] GO:0001503 |
ossification
|
ALOX15, ALPL, BCL2, EGFR, MMP2, MMP9, TEK |
4.51829 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, ALOX15, BCL2, CYP1A1, EGFR, PPARA, SMAD3 |
4.39198 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.37812 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, CDK6, CYP19A1, DUSP3, EGFR, ESR1, F3, FABP4, HSPA1A, IGF1R, MET, MMP2, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
4.34663 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, HSD11B2, MMP2, PPARA, SMAD3, SRC, TEK |
4.28554 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, HCAR2, HSPA1A, IGF1R, KDR, MET, MMP9, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
4.28554 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALOX15, ALPL, BCL2, CDK6, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP4, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, SMAD3, SRC |
4.26472 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ALOX15, BCL2, CDK6, CYP19A1, DUSP3, EGFR, ESR1, ESR2, HSPA1A, IGF1R, MET, MMP9, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
4.26472 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, PPARA |
4.26472 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, HSD11B2, MMP2, PPARA, SMAD3, SRC, TEK |
4.20657 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALPL, AOX1, BCL2, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TYR, XDH |
4.19649 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, HCAR2, HSPA1A, IGF1R, KDR, MET, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
4.13986 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, BCL2, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, MET, MMP9, PPARA, PTPN1, SMAD3, SRC, TEK |
4.02178 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, BCL2, CA2, CA7, CDK6, EGFR, HCAR2, KDR, SRC, TNKS, TNKS2 |
3.99727 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ALOX15, BCL2, CDC25B, DUSP3, EGFR, ESRRB, FABP3, FABP4, IGF1R, INSR, KDR, MMP9, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
3.95351 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
EGFR, F10, F3, INSR, MET, SRC, TEK, XDH |
3.9528 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, SRC |
3.9528 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, HSD11B2, MMP2, PPARA, SMAD3, SRC, TEK |
3.9528 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ALOX15, BCL2, CDC25B, DUSP3, EGFR, ESRRB, FABP3, FABP4, IGF1R, INSR, KDR, MMP9, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
3.92158 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, AKR1B1, ALOX15, BCL2, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, F10, F3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
3.9038 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
EGFR, F10, F3, INSR, MET, SRC, TEK |
3.81186 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, ALPL, BCL2, CA2, CA6, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, F10, F3, FABP3, FABP4, HSD11B2, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, TYR |
3.80874 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
ALOX15, BCL2, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK, TNKS, TNKS2 |
3.80643 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, BCL2, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, MET, MMP9, PTPN1, SMAD3, SRC, TEK |
3.7879 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
3.7648 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, BCL2, CDC25B, CDK6, CSNK2A1, EGFR, ESR1, F3, IGF1R, INSR, KDR, MMP2, MMP9, TEK |
3.70647 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
3.69505 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AOX1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FABP3, FABP4, FUT7, GBA2, HSPA1A, MMP1, MMP2, MMP9, SRC, XDH |
3.65883 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.64695 |
[BP] GO:0001952 |
regulation of cell-matrix adhesion
|
BCL2, CDK6, KDR, SMAD3, SRC, TEK |
3.63164 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, HCAR2, HSPA1A, IGF1R, KDR, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
3.62719 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.62719 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.62719 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
3.62275 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALOX15, ALPL, BCL2, CDK6, CYP1A1, CYP1B1, EGFR, ESR1, FABP4, IGF1R, INSR, KDR, MMP2, SMAD3, SRC |
3.51869 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ALOX15, BCL2, CDC25B, EGFR, ESRRB, FABP3, INSR, KDR, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
3.36426 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ALOX15, BCL2, CDC25B, EGFR, ESRRB, FABP3, INSR, KDR, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
3.36426 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
EGFR, IGF1R, INSR, KDR, MET, SRC, TEK |
3.31742 |
[BP] GO:0010810 |
regulation of cell-substrate adhesion
|
ALOX15, BCL2, CDK6, KDR, SMAD3, SRC, TEK |
3.29651 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ALOX15, BCL2, CDC25B, CSNK2A1, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, PPARA, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
3.29186 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4, GBA2 |
3.29186 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
EGFR, IGF1R, INSR, KDR, MET, SRC, TEK |
3.29163 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, ALPL, BCL2, CDC25B, CDK6, CSNK2A1, DUSP3, EGFR, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PTPN1, SRC, TEK, TNKS, XDH |
3.28759 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, BCL2, DUSP3, EGFR, ESR1, ESR2, GPR35, HSPA1A, IGF1R, MET, MMP9, PTPN1, SMAD3, SRC, XDH |
3.27026 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, BCL2, DUSP3, EGFR, ESR1, ESR2, GPR35, HSPA1A, IGF1R, MET, MMP9, PTPN1, SMAD3, SRC, XDH |
3.25621 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, DUSP3, EGFR, ESR1, F10, F3, FUT7, GBA2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TYR, XDH |
3.23234 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.21041 |
[BP] GO:0046777 |
protein autophosphorylation
|
CSNK2A1, EGFR, IGF1R, INSR, KDR, SRC, TEK |
3.21041 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, BCL2, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, MMP9, PTPN1, SMAD3, SRC, TEK |
3.21041 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
BCL2, CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
3.18479 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.18479 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, BCL2, CA2, CYP1A1, EGFR, HSD11B2, HSPA1A, MMP2, PPARA, SMAD3, SRC, TEK, TYR |
3.18479 |
[BP] GO:0010907 |
None
|
ESRRB, INSR, PPARA, SRC |
3.18159 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, SRC |
3.15122 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
ALOX15, BCL2, ESR1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, SMAD3, SRC, TEK, TNKS, TNKS2 |
3.11093 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
EGFR, IGF1R, INSR, KDR, MET, MMP2, MMP9, PTPN1, SRC, TEK |
3.09452 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ALOX15, BCL2, CDC25B, DUSP3, EGFR, ESRRB, FABP4, IGF1R, INSR, KDR, MMP9, PPARA, PTPN1, SRC, TEK, XDH |
3.07986 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, PPARA |
3.05564 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ALOX15, BCL2, CDC25B, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, PPARA, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
3.05521 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALOX15, ALPL, BCL2, CA2, CA9, CDK6, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP4, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NUAK1, PTPN1, SMAD3, SRC |
3.05239 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, ALPL, BCL2, CDC25B, CDK6, CSNK2A1, DUSP3, EGFR, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PTPN1, SRC, TEK, TNKS, XDH |
3.04311 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ALOX15, BCL2, CDC25B, CSNK2A1, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, PPARA, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
3.02273 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ALOX15, BCL2, CDC25B, CSNK2A1, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, PPARA, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
2.98788 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DUSP3, ESR1, HSPA1A, IGF1R, MET, MMP9, PTPN1, SRC, XDH |
2.98318 |
[BP] GO:0009894 |
regulation of catabolic process
|
ADORA1, BCL2, CSNK2A1, EGFR, ESRRB, HCAR2, HSPA1A, INSR, KDR, MET, PPARA, PTPN1, SMAD3 |
2.94641 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, ALOX15, BCL2, CYP19A1, CYP1A1, CYP1B1, GBA2, TYR |
2.92035 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, EGFR, HSPA1A |
2.9175 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, BCL2, CDC25B, CSNK2A1, DUSP3, EGFR, ESR1, F3, FABP4, HSPA1A, IGF1R, INSR, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, TNKS, XDH |
2.89948 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, EGFR, ESR1, FABP4, HSPA1A, MMP2, PPARA, PTPN1, SMAD3, SRC, TEK |
2.89594 |
[BP] GO:0071248 |
cellular response to metal ion
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9 |
2.88556 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.87986 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, BCL2, CA2, CYP1A1, CYP1A2, EGFR, FABP4, MMP9 |
2.86967 |
[BP] GO:0006468 |
protein phosphorylation
|
BCL2, CDC25B, CDK6, CSNK2A1, EGFR, IGF1R, INSR, KDR, MET, NUAK1, SRC, TEK, TNKS |
2.86623 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.85105 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, BCL2, CA12, CA2, CA7, EGFR, ESR1, FABP3, FABP4, GPR35, INSR, MET, SMAD3 |
2.83995 |
[BP] GO:0030155 |
regulation of cell adhesion
|
ALOX15, BCL2, CDK6, CYP1B1, DUSP3, KDR, NUAK1, PPARA, SMAD3, SRC, TEK |
2.83943 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
EGFR, IGF1R, INSR, KDR, MET, MMP2, MMP9, PTPN1, SMAD3, SRC, TEK |
2.81178 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.80505 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
2.80505 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALOX15, CSNK2A1, CYP19A1, CYP1A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
2.7931 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, BCL2, CA1, CSNK2A1, EGFR, F3, GPR35, IGF1R, INSR, KDR, MET, MMP2, MMP9, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2 |
2.77828 |
[BP] GO:0051701 |
interaction with host
|
EGFR, HSPA1A, INSR, MET, SMAD3, SRC |
2.77008 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ALOX15, BCL2, CDC25B, CSNK2A1, EGFR, ESR1, F3, HSPA1A, INSR, KDR, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
2.75211 |
[BP] GO:0001954 |
positive regulation of cell-matrix adhesion
|
CDK6, KDR, SMAD3, TEK |
2.74627 |
[BP] GO:0048732 |
gland development
|
BCL2, CSNK2A1, CYP19A1, EGFR, INSR, SMAD3, TYR |
2.7426 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, BCL2, CDC25B, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, F3, FABP4, GPR35, HSPA1A, IGF1R, INSR, MET, MMP9, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, TNKS, XDH |
2.7426 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
BCL2, HSPA1A, MMP9, PTPN1, SRC |
2.72661 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ALOX15, BCL2, CDC25B, EGFR, ESRRB, INSR, KDR, MMP9, PTPN1, SRC, TEK, XDH |
2.66764 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, SRC |
2.65505 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, FABP3, HSD11B2, IGF1R, INSR, PPARA, SRC, TEK |
2.65014 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPR35, HSPA1A, IGF1R, KDR, MET, MMP9, PPARA, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
2.63566 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPR35, HCAR2, HSPA1A, IGF1R, KDR, MET, MMP9, PPARA, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
2.63503 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
BCL2, CYP1B1, EGFR, INSR, SMAD3, XDH |
2.63503 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ALOX15, DUSP3, EGFR, IGF1R, INSR, KDR, PTPN1, SRC, TEK, XDH |
2.60854 |
[BP] GO:0048729 |
tissue morphogenesis
|
BCL2, CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
2.60854 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
BCL2, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.6022 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9 |
2.6009 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, CSNK2A1, CYP1B1, DUSP3, ESR1, FABP4, GPR35, IGF1R, MET, MMP9, PPARA, PTPN1, SRC, TNKS |
2.5935 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, BCL2, CYP1B1, EGFR, MMP9, SRC |
2.57702 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, BCL2, CA2, CDK6, CYP1B1, EGFR, ESR1, ESRRA, ESRRB, F3, GPR35, HCAR2, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK, TNKS2, XDH |
2.57532 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, SRC |
2.56739 |
[BP] GO:0009895 |
negative regulation of catabolic process
|
ADORA1, BCL2, EGFR, HCAR2, MET, PPARA, SMAD3 |
2.55153 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, BCL2, CDC25B, CYP19A1, EGFR, ESR1, ESRRB, HSD17B2, INSR, SRC |
2.54918 |
[BP] GO:0010676 |
None
|
ESRRB, INSR, PPARA, SRC |
2.5448 |
[BP] GO:0010811 |
positive regulation of cell-substrate adhesion
|
ALOX15, CDK6, KDR, SMAD3, TEK |
2.54123 |
[BP] GO:0032787 |
None
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, GBA2, PPARA |
2.53816 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, BCL2, CA9, CDK6, CYP1A1, CYP1B1, EGFR, FABP3, HSD11B2, KDR, SRC |
2.53731 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, GBA2 |
2.53731 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.53006 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, BCL2, CDC25B, CYP19A1, CYP1A1, EGFR, ESR1, ESRRB, HSD11B2, HSD17B2, INSR, MMP2, MMP9, SRC |
2.52057 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, CYP1B1, EGFR, MMP9, SRC |
2.51753 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ALOX15, BCL2, CDC25B, EGFR, ESR1, F3, HSPA1A, INSR, KDR, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
2.51753 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, BCL2, CA12, CA2, CA7, EGFR, ESR1, FABP3, FABP4, GPR35, INSR, MET, SMAD3, SRC |
2.51606 |
[BP] GO:0044089 |
positive regulation of cellular component biogenesis
|
ALOX15, ESR1, HSPA1A, KDR, MET, MMP1, SMAD3, SRC, TEK |
2.50973 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.5087 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.5087 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.49041 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.49041 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.49041 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ALOX15, DUSP3, EGFR, KDR, PTPN1, SRC, TEK |
2.4795 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ALOX15, BCL2, CDC25B, DUSP3, EGFR, FABP4, IGF1R, INSR, KDR, MMP9, PTPN1, SRC, TEK, XDH |
2.46619 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, EGFR, FABP3, HSD11B2, IGF1R, INSR, MMP2, PPARA, SRC, TEK, TYR |
2.44345 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, BCL2, CDC25B, EGFR, ESR1, ESR2, F3, HSPA1A, INSR, MET, MMP9, PTPN1, SMAD3, SRC, TEK, TNKS, XDH |
2.43651 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.43651 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
ADORA1, CYP19A1, PPARA, SMAD3, TEK |
2.42158 |
[BP] GO:0050727 |
regulation of inflammatory response
|
ADORA1, CYP19A1, EGFR, ESR1, FABP4, PPARA, SMAD3, TEK |
2.40853 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, CYP1B1, EGFR, HSPA1A, MMP9, SRC |
2.38138 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ALOX15, EGFR, INSR, KDR, PTPN1, SRC, TEK, XDH |
2.37543 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ALOX15, BCL2, CDC25B, DUSP3, EGFR, FABP4, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, PTPN1, SRC, TEK, XDH |
2.36901 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, EGFR, ESR1, F3, FABP4, KDR, MET, PPARA, SMAD3, TEK |
2.34521 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.32306 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ALOX15, BCL2, CDC25B, EGFR, INSR, KDR, MMP9, PTPN1, SRC, TEK, XDH |
2.28117 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
BCL2, CDC25B, CDK6, CYP1A1, DUSP3, EGFR, HSPA1A, INSR, SMAD3, TNKS |
2.2751 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.27444 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.27444 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, SRC, TEK |
2.27444 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, AKR1B1, BCL2, CA1, CA2, CDK6, CSNK2A1, CYP1B1, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, MMP2, MMP9, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2 |
2.26652 |
[BP] GO:0043281 |
regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
CSNK2A1, F3, MMP9, SMAD3, SRC, XDH |
2.26027 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.24587 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.24587 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.24587 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, KDR, SRC |
2.24587 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.23515 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.23515 |
[BP] GO:0051054 |
positive regulation of DNA metabolic process
|
EGFR, IGF1R, INSR, SRC, TNKS, TNKS2 |
2.19792 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, EGFR, FABP3, HSD11B2, IGF1R, INSR, MMP2, PPARA, SRC, TEK, TYR |
2.19792 |
[BP] GO:0050927 |
None
|
F3, KDR, SMAD3 |
2.18926 |
[BP] GO:0045913 |
None
|
ESRRB, INSR, PPARA, SRC |
2.18878 |
[BP] GO:0035239 |
tube morphogenesis
|
BCL2, EGFR, ESR1, MET, SMAD3, SRC |
2.18188 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, ALOX15, BCL2, CA2, CA7, CYP19A1, EGFR, GPR35, HCAR2, HSPA1A, INSR, MMP9, PPARA, PTPN1, SMAD3, SRC |
2.1554 |
[BP] GO:0050926 |
None
|
F3, KDR, SMAD3 |
2.14714 |
[BP] GO:1903393 |
None
|
KDR, SMAD3, TEK |
2.14714 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, BCL2, CA2, EGFR, HSD11B2, SRC |
2.14612 |
[BP] GO:0016310 |
phosphorylation
|
BCL2, CDC25B, CDK6, CSNK2A1, EGFR, IGF1R, INSR, KDR, MET, NUAK1, SRC, TEK, TNKS |
2.13296 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, EGFR, FABP3, HSD17B2, KDR, MMP2, SRC |
2.11882 |
[BP] GO:1904357 |
None
|
SRC, TNKS, TNKS2 |
2.10362 |
[BP] GO:0032868 |
None
|
FABP3, HSD11B2, INSR, PPARA, SRC |
2.09864 |
[BP] GO:0031334 |
positive regulation of protein complex assembly
|
ALOX15, ESR1, HSPA1A, MET, MMP1, SRC |
2.08979 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
CA2, CA7, EGFR, HCAR2, TNKS, TNKS2 |
2.08084 |
[BP] GO:0043696 |
None
|
CDK6, ESRRB |
2.07023 |
[BP] GO:0043697 |
None
|
CDK6, ESRRB |
2.07023 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.07023 |
[BP] GO:0007598 |
None
|
F10, F3 |
2.07023 |
[BP] GO:0050678 |
None
|
CDK6, EGFR, F3, KDR, SMAD3, TEK, XDH |
2.07023 |
[BP] GO:0002682 |
regulation of immune system process
|
ADORA1, ALOX15, BCL2, CA2, CDK6, CYP19A1, DUSP3, ESR1, ESRRA, HCAR2, HSPA1A, MMP2, PTPN1, SMAD3, SRC |
2.05372 |
[BP] GO:0032845 |
None
|
ADORA1, BCL2, SRC, TNKS, TNKS2 |
2.0439 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
BCL2, DUSP3, EGFR, ESR1, ESR2, HSPA1A, IGF1R, MET, MMP9, PTPN1, SMAD3, SRC, XDH |
2.03756 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9 |
2.03736 |
[BP] GO:0042060 |
None
|
ALOX15, EGFR, PPARA, SMAD3 |
2.01683 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, DUSP3, EGFR, IGF1R, INSR, PTPN1, SRC |
2.00006 |
[BP] GO:2000116 |
regulation of cysteine-type endopeptidase activity
|
CSNK2A1, F3, MMP9, SMAD3, SRC, XDH |
2.00006 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADORA1, CA2, CA4, CA9, EGFR, TEK |
2.46631 |
[CC] GO:0031233 |
None
|
CA4, F10, F3 |
2.43651 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, GBA2, HSD11B1, HSD11B2, HSD17B2 |
2.39213 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, F10, GBA2, HSD11B1, HSD11B2, HSD17B2, PTPN1 |
2.22352 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, AOX1, BCL2, CA1, CA2, CA4, CA5A, CA5B, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DUSP3, EGFR, ESR1, ESR2, F10, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, INSR, KDR, MMP2, MMP9, PTPN1, SMAD3, SRC, TNKS, TNKS2, TYR, XDH |
2.17948 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
17.3081 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, AOX1, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9, PPARA, PTPN1, SMAD3, TNKS, TYR, XDH |
16.3976 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALPL, AOX1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DUSP3, EGFR, F10, F3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PTPN1, SRC, TEK, TNKS, TNKS2, TYR, XDH |
12.2154 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
11.0692 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX15, ALPL, AOX1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TYR, XDH |
10.0268 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
9.83661 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9, PPARA, PTPN1, SMAD3, TNKS |
8.82525 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
6.67388 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
6.40758 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX15, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD11B1, HSD11B2, HSD17B1, HSD17B2, TYR, XDH |
6.0463 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALPL, AOX1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, ESRRA, ESRRB, F10, MMP1, MMP2, MMP9, NUAK1, PPARA, PTPN1, SMAD3, TNKS, TNKS2, TYR, XDH |
5.87168 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, XDH |
5.78047 |
[MF] GO:0046872 |
metal ion binding
|
ALOX15, ALPL, AOX1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, ESRRA, ESRRB, F10, MMP1, MMP2, MMP9, NUAK1, PPARA, PTPN1, SMAD3, TNKS, TNKS2, TYR, XDH |
5.56126 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 |
5.31316 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, XDH |
5.17671 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
4.971 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
EGFR, IGF1R, INSR, KDR, MET, TEK |
4.71134 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, SRC |
4.22534 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
EGFR, IGF1R, INSR, KDR, MET, TEK |
4.19649 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, SRC |
4.0292 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 |
4.02178 |
[MF] GO:0005496 |
steroid binding
|
ESR1, ESR2, ESRRA, ESRRB, HSD11B2, HSD17B1 |
4.00177 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD11B2, HSD17B1, SRC, XDH |
3.94951 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.88514 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.88514 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
3.77199 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.5433 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.4636 |
[MF] GO:0008289 |
lipid binding
|
ALOX15, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, HSD11B2, HSD17B1, PPARA |
3.44183 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
EGFR, IGF1R, INSR, KDR, MET, SRC, TEK |
3.38069 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.35283 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.31742 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, INSR, KDR |
3.29651 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6 |
3.13456 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, PPARA, TEK |
2.9628 |
[MF] GO:0008144 |
drug binding
|
ACHE, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, EGFR, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PPARA, SRC, TEK |
2.9343 |
[MF] GO:0042562 |
hormone binding
|
ACHE, EGFR, HSD17B1, IGF1R, INSR |
2.89848 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, EGFR, ESRRB, IGF1R, INSR, KDR, MMP9, PPARA, PTPN1, SMAD3, SRC |
2.87099 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.85105 |
[MF] GO:0003845 |
None
|
HSD11B1, HSD11B2 |
2.85105 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
2.85105 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, CDK6, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, PPARA, TEK |
2.80327 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.77828 |
[MF] GO:0019902 |
phosphatase binding
|
BCL2, EGFR, MET, PPARA, PTPN1, SMAD3 |
2.6926 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, CSNK2A1, EGFR, ESRRB, IGF1R, INSR, KDR, MMP9, PPARA, PTPN1, SMAD3, SRC |
2.67455 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.51753 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, PPARA, SMAD3, TEK |
2.51606 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, PPARA, TEK |
2.46896 |
[MF] GO:0004672 |
protein kinase activity
|
CDK6, CSNK2A1, EGFR, IGF1R, INSR, KDR, MET, NUAK1, SRC, TEK |
2.3028 |
[MF] GO:0019899 |
enzyme binding
|
BCL2, CDC25B, CYP1A1, CYP1A2, CYP2A6, DUSP3, EGFR, ESR1, ESR2, ESRRB, F3, HSPA1A, MET, PPARA, PTPN1, SMAD3, SRC, TEK, TNKS2 |
2.2902 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.24587 |
[MF] GO:0019838 |
growth factor binding
|
EGFR, IGF1R, INSR, KDR, TEK |
2.2128 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.07023 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.07023 |